Secondary Logo

Journal Logo

November 5, 2013 - Volume 126 - Issue 21
pp: 4003-4200

Oral fibrinogen-depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel-group and controlled clinical trial

CAO, Yong-jun; ZHANG, Xia; WANG, Wan-hua; More

Chinese Medical Journal. 126(21):4060-4065, November 5, 2013.

Differences in the population of genetics ofMycobacterium tuberculosisbetween urban migrants and local residents in Beijing, China

DAI, Guang-ming; ZHANG, Zhi-guo; DING, Peng-ju; More

Chinese Medical Journal. 126(21):4066-4071, November 5, 2013.